A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : dMMR

Search Conditions:
Search Keyword : dMMR
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: dMMR
Appearance Frequency: 171 time(s)
Long forms: 27

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
deficient mismatch repair
(46 times)
Neoplasms
(23 times)
CRC (11 times)
pMMR (11 times)
MSI (9 times)
2009 Colorectal cancer due to deficiency in DNA mismatch repair function: a review.
deficient MMR
(30 times)
Neoplasms
(17 times)
MMR (27 times)
pMMR (16 times)
CRC (15 times)
2011 DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy.
DNA mismatch repair
(28 times)
Neoplasms
(20 times)
pMMR (8 times)
MSI (6 times)
DFS (5 times)
2008 Clustering of Lynch syndrome malignancies with no evidence for a role of DNA mismatch repair.
MMR-deficient
(15 times)
Neoplasms
(8 times)
MMR (16 times)
MSI (6 times)
CRC (5 times)
2012 Relevance, pathogenesis, and testing algorithm for mismatch repair-defective colorectal carcinomas: a report of the association for molecular pathology.
DNA mismatch repair deficiency
(13 times)
Neoplasms
(8 times)
CRC (5 times)
MSI (4 times)
CI (2 times)
2016 DNA Mismatch Repair Deficiency in Rectal Cancer: Benchmarking Its Impact on Prognosis, Neoadjuvant Response Prediction, and Clinical Cancer Genetics.
deficient mismatch repair system
(8 times)
Neoplasms
(5 times)
CRC (5 times)
CN (1 time)
CPIs (1 time)
2009 Deficient mismatch repair system in patients with sporadic advanced colorectal cancer.
MMR deficiency
(6 times)
Neoplasms
(4 times)
MMR (5 times)
CRC (2 times)
IHC (2 times)
2012 Use of mismatch repair immunohistochemistry and microsatellite instability testing: exploring Canadian practices.
defective MMR
(2 times)
Neoplasms
(1 time)
MMR (2 times)
EEC (1 time)
HIR (1 time)
2019 Mismatch repair deficiency identifies patients with high-intermediate-risk (HIR) endometrioid endometrial cancer at the highest risk of recurrence: A prognostic biomarker.
determine the frequency of mismatch repair deficiency
(2 times)
General Surgery
(1 time)
CRC (2 times)
IHC (2 times)
CAP (1 time)
2017 Mismatch repair deficiency screening in colorectal carcinoma by a four-antibody immunohistochemical panel in Pakistani population and its correlation with histopathological parameters.
10  DNA mismatch repair system
(2 times)
Neoplasms
(1 time)
CIMP (1 time)
CMS (1 time)
CRC (1 time)
2015 [DNA mismatch repair and BRAF status in colorectal cancer: Interest for the therapeutic management?].
11  DNA MMR
(2 times)
Genetics
(1 time)
MMR (2 times)
pMMR (2 times)
CRC (1 time)
2016 Association between expression of DNA mismatch repair genes and clinical features and prognosis of patients with radical resection of colon cancer.
12  mismatch-repair deficient
(2 times)
Translational Medical Research
(1 time)
BTCs (1 time)
LS (1 time)
MSI-H (1 time)
2018 Clinical and Genetic Implications of DNA Mismatch Repair Deficiency in Biliary Tract Cancers Associated with Lynch Syndrome.
13  data on mismatch repair deficiency
(1 time)
Antineoplastic Agents
(1 time)
MMR (1 time)
OXA (1 time)
2016 [Characteristics and Outcomes of Treatment in Patients with Stage IV Colorectal Cancer with Mismatch Repair Deficiency].
14  defect in the MMR system
(1 time)
Gastroenterology
(1 time)
DFS (1 time)
HR (1 time)
IHC (1 time)
2013 Management of stage II colon cancer - the use of molecular biomarkers for adjuvant therapy decision.
15  defect MMR
(1 time)
Neoplasms
(1 time)
CRC (1 time)
mCRC (1 time)
MMR (1 time)
0 [Immunotherapy of Colorectal and Anal Carcinoma].
16  defects of MMR
(1 time)
Medicine
(1 time)
MMR (1 time)
2014 [Relation between mismatch repair genes and colon cancer].
17  deficiencies in mismatch repair genes
(1 time)
Neoplasms
(1 time)
CRC (1 time)
IHC (1 time)
OS (1 time)
2017 Impact of age and mismatch repair status on survival in colorectal cancer.
18  deficient expression of the inherited MMR gene product
(1 time)
Neoplasms
(1 time)
LS (1 time)
MMR (1 time)
MSI-H (1 time)
2019 Oral squamous cell cancer in a patient with Lynch syndrome.
19  deficient MMR phenotype
(1 time)
Neoplasms
(1 time)
MMR (1 time)
2018 Sporadic endometrial adenocarcinoma with MMR deficiency due to biallelic MSH2 somatic mutations.
20  deficient protein expression of one or more MMR genes
(1 time)
Neoplasms
(1 time)
LS (1 time)
MMR (1 time)
NCCN (1 time)
2019 Rationale for evaluating breast cancers of Lynch syndrome patients for mismatch repair gene expression.
21  demonstrated in gastrointestinal malignancies with mismatch repair deficiencies
(1 time)
Neoplasms
(1 time)
CEA (1 time)
2018 Upper gastrointestinal malignancies in 2017: current perspectives and future approaches.
22  detected to be MMR-deficient
(1 time)
Medicine
(1 time)
CRC (1 time)
IHC (1 time)
LS (1 time)
2018 Prevalence and clinicopathological characteristics of mismatch repair-deficient colorectal carcinoma in early onset cases as compared with late-onset cases: a retrospective cross-sectional study in Northeastern Iran.
23  diagnosed with mismatch repair defective
(1 time)
Neoplasms
(1 time)
CI (1 time)
HR (1 time)
2013 Defective mismatch repair and benefit from bevacizumab for colon cancer: findings from NSABP C-08.
24  differentiated tumors, microsatellite repair deficiency
(1 time)
Neoplasms
(1 time)
CRC (1 time)
LCC (1 time)
OS (1 time)
2017 Is there a prognostic value of tumor location among Chinese patients with colorectal cancer?
25  DNA mismatch repair protein deficiency
(1 time)
Pathology
(1 time)
CRC (1 time)
IHC (1 time)
2019 DNA mismatch repair deficiency but not ARID1A loss is associated with prognosis in small intestinal adenocarcinoma.
26  Dukes stages and mismatch repair deficiency
(1 time)
Neoplasms
(1 time)
CECT (1 time)
CIMP (1 time)
CRC (1 time)
2019 The role of mSEPT9 in screening, diagnosis, and recurrence monitoring of colorectal cancer.
27  durable responses in patients with CRC who have mismatch repair-deficient
(1 time)
Neoplasms
(1 time)
CRC (1 time)
FDA (1 time)
MSI-H (1 time)
2020 Perspectives on Treatment of Metastatic Colorectal Cancer with Immune Checkpoint Inhibitor Therapy.